Here is a list of articles about MOTS-c peptide:
- MOTS-c: A novel mitochondrial-derived peptide regulating muscle and fat metabolism. Lee C, et al. Free Radic Biol Med.
- MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Lee C, et al. Cell Metab.
- MOTS-c prevents pancreatic islet destruction in autoimmune diabetes. Kong BS, et al. Cell Rep.
- MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Reynolds JC, et al. Nat Commun.
- MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress. Kim KH, et al. Cell Metab.
- MOTS-c: an equal opportunity insulin sensitizer. Kim S-J, et al. J Mol Med (Berl).
- Mitochondria-derived peptide MOTS-c, Diabetes, and Aging-Related Diseases. Park J-S, et al. Diabetes Metab J.
- Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. Wei W, et al. J Transl Med.
- Mitochondrial-derived peptide MOTS-c: a new therapeutic target for metabolic disorders and age-related diseases. Kim K-H, et al. Front Physiol.
- MOTS-c: a mitochondrial-derived peptide with potential therapeutic applications for neurodegenerative diseases. Lee H, et al. Int J Mol Sci.
- MOTS-c: a mitochondrial-derived peptide with potential therapeutic applications for cardiovascular diseases. Zhao Y, et al. Front Pharmacol.
In addition to these articles, there are also a number of preclinical studies and clinical trials that have been conducted on MOTS-c peptide. These studies have shown that MOTS-c peptide has the potential to be used to treat a variety of conditions, including obesity, type 2 diabetes, muscle wasting, osteoporosis, and neurodegenerative diseases.
Overall, MOTS-c peptide is a promising new therapeutic target for a variety of conditions. However, more research is needed to fully understand its safety and efficacy.
